\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ was\\ noncontributory\\.\\ \\ thyroid\\ was\\ non\\ tender\\,\\ not\\ enlarged\\,\\ and\\ no\\ nodules\\ were\\ palpated\\.\ \(0\)\
\-\ free\\ t4\\:\\ 3\\.16\\ \\(nl\\ 0\\.71\\-1\\.85\\)\ \(0\)\
\-\ tsh\\:\\ \\<0\\.08\\ \\(nl\\ 0\\.49\\-4\\.67\\)\ \(0\)\
\-\ t3\\:\\ 154\\ \\(nl\\ 59\\-174\\)\ \(0\)\
\-\ thyroglobulin\\ antibody\\:\\ \\<2\\.0\\ \\(nl\\)\ \(0\)\
\-\ thyroid\\ stimulating\\ immunoglobulin\\:92\\ \\ \\ \\(nl\\)\ \(0\)\
\-\ crp\\:\\ 0\\.109\\ \\(nl\\ 0\\-0\\.7\\)\ \(0\)\
\-\ the\\ diagnosis\\ of\\ thyroiditis\\ was\\ made\\ by\\ exclusion\\ of\\ other\\ causes\\.\ \(0\)\
\-\ no\\ treatment\\ was\\ given\\ \\(expectant\\ management\\)\\,\\ and\\ the\\ patient\\ will\\ follow\\ up\\ over\\ the\\ next\\ 1\\-2\\ months\\ with\\ his\\ endocrinologist\\.\ \(0\)\
\-\ heterogeneously\\ decreased\\ uptake\\ of\\ radiotracer\\ throughout\\ both\\ lobes\\ of\\ the\\ thyroid\\.\ \(0\)\
\-\ 4\\ hour\\ radioactive\\ iodine\\ uptake\\ \\(raiu\\)\\:\\ 1\\.1\\%\ \(0\)\
\-\ 24\\ hour\\ raiu\\:\\ 0\\.8\\%\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ ddx\\ for\\ markedly\\ decreased\\ tracer\\ uptake\\:\ \(0\)\
\-\ factitious\\/iatrogenic\\ thyroid\\ hormone\\ ingestion\ \(1\)\
\-\ increased\\ iodine\\ pool\\ \\(e\\.g\\.\\ recent\\ contrast\\ media\\ study\\ or\\ exogenous\\ iodine\\)\ \(0\)\
\-\ anti\\-thyroid\\ medicine\ \(1\)\
\-\ acute\\ or\\ subacute\\ thyroiditis\ \(1\)\
\-\ ectopic\\ thyroid\\ tissue\ \(2\)\
\-\ struma\\ ovarii\ \(1\)\
\-\ toxic\\ intrathoracic\\ goiter\ \(1\)\
\-\ 63\\ yo\\ m\\ w\\/\\ pmh\\ significant\\ for\\ mitral\\ valve\\ replacement\\ 3\\ years\\ ago\\ who\\ now\\ complains\\ of\\ 2\\-3\\ month\\ h\\/o\\ 30\\ pound\\ weight\\ loss\\,\\ decreased\\ appetite\\,\\ increased\\ fatigue\\,\\ and\\ occasional\\ light\\ headedness\\.\\ \\ the\\ patient\\ had\\ no\\ h\\/o\\ recent\\ viral\\ illnesses\\.\ \(0\)\
\-\ the\\ patient\\ was\\ very\\ concerned\\ about\\ his\\ symptoms\\,\\ specifically\\ his\\ loss\\ of\\ weight\\.\\ \\ he\\ had\\ already\\ been\\ to\\ an\\ oncologist\\ who\\ \\"ruled\\ out\\"\\ a\\ malignancy\\.\\ \\ there\\ was\\ some\\ discussion\\ with\\ the\\ endocrinologist\\ of\\ initiating\\ steroids\\,\\ but\\ it\\ was\\ decided\\ that\\ the\\ risks\\ outweighed\\ the\\ benefits\\.\\ \\ therefore\\,\\ after\\ educating\\ the\\ patient\\ about\\ the\\ nature\\ and\\ expected\\ timecourse\\ of\\ this\\ self\\-limited\\ illness\\,\\ the\\ clinical\\ team\\ decided\\ on\\ expectant\\ management\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nl\\:\\ 0\\.39508544544904517\ \(0\)\
\-\ thyroid\\:\\ 0\\.2829165074405191\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.199399419327394\ \(0\)\
\-\ iodine\\:\\ 0\\.19845741687595234\ \(0\)\
\-\ endocrinologist\\:\\ 0\\.17263027266716136\ \(0\)\
\-\ expectant\\:\\ 0\\.1655520769974931\ \(0\)\
\-\ was\\:\\ 0\\.14637392301681942\ \(0\)\
\-\ the\\:\\ 0\\.1436658581347801\ \(0\)\
\-\ raiu\\:\\ 0\\.1434675017880567\ \(0\)\
\-\ uptake\\:\\ 0\\.13840921916922425\ \(0\)\
\-\ decided\\:\\ 0\\.13715435379088367\ \(0\)\
\-\ hour\\:\\ 0\\.11378528495030459\ \(0\)\
\-\ subacute\\:\\ 0\\.11229973902985761\ \(0\)\
\-\ decreased\\:\\ 0\\.11149551616564347\ \(0\)\
\-\ his\\:\\ 0\\.10916548542573247\ \(0\)\
\-\ timecourse\\:\\ 0\\.09595290787104353\ \(0\)\
\-\ of\\:\\ 0\\.09393372449610868\ \(0\)\
\-\ educating\\:\\ 0\\.09168812602569375\ \(0\)\
\-\ about\\:\\ 0\\.08983611766522082\ \(0\)\
\-\ headedness\\:\\ 0\\.08866221515126736\ \(0\)\
\-\ management\\:\\ 0\\.08863827082975026\ \(0\)\
\-\ initiating\\:\\ 0\\.08439743330591758\ \(0\)\
\-\ outweighed\\:\\ 0\\.08439743330591758\ \(0\)\
\-\ weight\\:\\ 0\\.0836818286292005\ \(0\)\
\-\ ovarii\\:\\ 0\\.08277603849874655\ \(0\)\
\-\ recent\\:\\ 0\\.08125184264989023\ \(0\)\
\-\ 154\\:\\ 0\\.08013265146056779\ \(0\)\
\-\ thyroglobulin\\:\\ 0\\.08013265146056779\ \(0\)\
\-\ exogenous\\:\\ 0\\.07902444361380451\ \(0\)\
\-\ patient\\:\\ 0\\.07805982630908988\ \(0\)\
\-\ stimulating\\:\\ 0\\.07710674058614142\ \(0\)\
\-\ oncologist\\:\\ 0\\.07626483167779788\ \(0\)\
\-\ pound\\:\\ 0\\.07548534577897038\ \(0\)\
\-\ illnesses\\:\\ 0\\.07548534577897038\ \(0\)\
\-\ loss\\:\\ 0\\.07310828047648547\ \(0\)\
\-\ radioactive\\:\\ 0\\.0722732663944197\ \(0\)\
\-\ intrathoracic\\:\\ 0\\.0712205639336206\ \(0\)\
\-\ exclusion\\:\\ 0\\.07026370037033842\ \(0\)\
\-\ concerned\\:\\ 0\\.07026370037033842\ \(0\)\
\-\ benefits\\:\\ 0\\.06938667207634165\ \(0\)\
\-\ tracer\\:\\ 0\\.06897413895802172\ \(0\)\
\-\ antibody\\:\\ 0\\.06857717689544184\ \(0\)\
\-\ risks\\:\\ 0\\.06819465305919423\ \(0\)\
\-\ who\\:\\ 0\\.06787929899818798\ \(0\)\
\-\ goiter\\:\\ 0\\.06746896904867855\ \(0\)\
\-\ media\\:\\ 0\\.06679013699193889\ \(0\)\
\-\ mitral\\:\\ 0\\.0652630768640153\ \(0\)\
\-\ t3\\:\\ 0\\.06498257367464352\ \(0\)\
\-\ ingestion\\:\\ 0\\.06498257367464352\ \(0\)\
\-\ increased\\:\\ 0\\.06489018964298464\ \(0\)\
\-\ palpated\\:\\ 0\\.06444305817425218\ \(0\)\
\-\ crp\\:\\ 0\\.06418333519492846\ \(0\)\
\-\ team\\:\\ 0\\.06418333519492846\ \(0\)\
\-\ already\\:\\ 0\\.06368237164813513\ \(0\)\
\-\ pool\\:\\ 0\\.06297300765056225\ \(0\)\
\-\ appetite\\:\\ 0\\.06297300765056225\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.0623084764066734\ \(0\)\
\-\ hormone\\:\\ 0\\.061093483417018264\ \(0\)\
\-\ specifically\\:\\ 0\\.06035505773779548\ \(0\)\
\-\ illness\\:\\ 0\\.06035505773779548\ \(0\)\
\-\ t4\\:\\ 0\\.060178276328902394\ \(0\)\
\-\ ruled\\:\\ 0\\.06000441706094531\ \(0\)\
\-\ had\\:\\ 0\\.0597883160115672\ \(0\)\
\-\ no\\:\\ 0\\.05853385778311226\ \(0\)\
\-\ fatigue\\:\\ 0\\.05811549174270146\ \(0\)\
\-\ tsh\\:\\ 0\\.05797238414423913\ \(0\)\
\-\ 63\\:\\ 0\\.05797238414423913\ \(0\)\
\-\ occasional\\:\\ 0\\.05783119751121569\ \(0\)\
\-\ ddx\\:\\ 0\\.057021702330315886\ \(0\)\
\-\ next\\:\\ 0\\.05603101801046187\ \(0\)\
\-\ viral\\:\\ 0\\.05534480213718066\ \(0\)\
\-\ valve\\:\\ 0\\.05501778368689724\ \(0\)\
\-\ pmh\\:\\ 0\\.054292099676381565\ \(0\)\
\-\ expected\\:\\ 0\\.054093636312453515\ \(0\)\
\-\ replacement\\:\\ 0\\.05389884840806542\ \(0\)\
\-\ noncontributory\\:\\ 0\\.05342709910951758\ \(0\)\
\-\ markedly\\:\\ 0\\.052975602919687115\ \(0\)\
\-\ nature\\:\\ 0\\.052975602919687115\ \(0\)\
\-\ medicine\\:\\ 0\\.05288758360912623\ \(0\)\
\-\ therefore\\:\\ 0\\.05288758360912623\ \(0\)\
\-\ steroids\\:\\ 0\\.052713724341169145\ \(0\)\
\-\ discussion\\:\\ 0\\.05254269217878786\ \(0\)\
\-\ radiotracer\\:\\ 0\\.052374396648718485\ \(0\)\
\-\ complains\\:\\ 0\\.05220875155238657\ \(0\)\
\-\ light\\:\\ 0\\.051965074718404405\ \(0\)\
\-\ lobes\\:\\ 0\\.050060762203347375\ \(0\)\
\-\ pe\\:\\ 0\\.04960194975537613\ \(0\)\
\-\ and\\:\\ 0\\.04959298201001232\ \(0\)\
\-\ nodules\\:\\ 0\\.04767356288095245\ \(0\)\
\-\ free\\:\\ 0\\.04670509873611335\ \(0\)\
\-\ made\\:\\ 0\\.046275722946089747\ \(0\)\
\-\ causes\\:\\ 0\\.04533716791002634\ \(0\)\
\-\ malignancy\\:\\ 0\\.04491805883261041\ \(0\)\
\-\ throughout\\:\\ 0\\.04412684036566014\ \(0\)\
\-\ ago\\:\\ 0\\.0439006328036416\ \(0\)\
\-\ tender\\:\\ 0\\.04386340003474038\ \(0\)\
\-\ very\\:\\ 0\\.04304152316173219\ \(0\)\
\-\ 24\\:\\ 0\\.04253816174732756\ \(0\)\
\-\ or\\:\\ 0\\.04174579616155019\ \(0\)\
\-\ given\\:\\ 0\\.041273836062642816\ \(0\)\
\-\ now\\:\\ 0\\.041187027485462435\ \(0\)\
\-\ 30\\:\\ 0\\.040930819375421694\ \(0\)\
\-\ enlarged\\:\\ 0\\.04090273325397667\ \(0\)\
\-\ study\\:\\ 0\\.040015612287305824\ \(0\)\
\-\ out\\:\\ 0\\.03943878203241849\ \(0\)\
\-\ will\\:\\ 0\\.03861754319924801\ \(0\)\
\-\ clinical\\:\\ 0\\.03802511833777272\ \(0\)\
\-\ some\\:\\ 0\\.037751354733999855\ \(0\)\
\-\ yo\\:\\ 0\\.03748453613222033\ \(0\)\
\-\ years\\:\\ 0\\.03677913804165031\ \(0\)\
\-\ month\\:\\ 0\\.036498634852278555\ \(0\)\
\-\ for\\:\\ 0\\.03637102060130369\ \(0\)\
\-\ he\\:\\ 0\\.0355297435618636\ \(0\)\
\-\ been\\:\\ 0\\.03495662341233999\ \(0\)\
\-\ months\\:\\ 0\\.03492479813471215\ \(0\)\
\-\ significant\\:\\ 0\\.03464262259519275\ \(0\)\
\-\ both\\:\\ 0\\.03345889327733017\ \(0\)\
\-\ over\\:\\ 0\\.03336258426748445\ \(0\)\
\-\ symptoms\\:\\ 0\\.032828548447462656\ \(0\)\
\-\ follow\\:\\ 0\\.032345158238515644\ \(0\)\
\-\ tissue\\:\\ 0\\.03147459704813543\ \(0\)\
\-\ other\\:\\ 0\\.031158913230803564\ \(0\)\
\-\ diagnosis\\:\\ 0\\.031103524760358627\ \(0\)\
\-\ were\\:\\ 0\\.030928216598366396\ \(0\)\
\-\ it\\:\\ 0\\.03071311204184556\ \(0\)\
\-\ up\\:\\ 0\\.029679691431050235\ \(0\)\
\-\ but\\:\\ 0\\.029670046087658636\ \(0\)\
\-\ contrast\\:\\ 0\\.029152728114735335\ \(0\)\
\-\ after\\:\\ 0\\.029106936809362206\ \(0\)\
\-\ treatment\\:\\ 0\\.028581137780679694\ \(0\)\
\-\ non\\:\\ 0\\.02846873457286806\ \(0\)\
\-\ that\\:\\ 0\\.026037708071955067\ \(0\)\
\-\ by\\:\\ 0\\.025479438906080808\ \(0\)\
\-\ there\\:\\ 0\\.023873775433908805\ \(0\)\
\-\ not\\:\\ 0\\.023686534692652476\ \(0\)\
\-\ with\\:\\ 0\\.023497462468527984\ \(0\)\
\-\ an\\:\\ 0\\.02294376173242899\ \(0\)\
\-\ this\\:\\ 0\\.020617047386217828\ \(0\)\
\-\ on\\:\\ 0\\.018121000768595612\ \(0\)\
\-\ to\\:\\ 0\\.014999858041775211\ \(0\)\
